Bulonza R, Watkins K, Parsons R, Sunderland B, Whitehouse A, Caccetta R
Autism. 2024; 28(8):2002-2013.
PMID: 38385262
PMC: 11301957.
DOI: 10.1177/13623613231226099.
Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D
Cochrane Database Syst Rev. 2023; 10:CD011769.
PMID: 37811711
PMC: 10561353.
DOI: 10.1002/14651858.CD011769.pub2.
Perone M, Lerman D, Peterson S, Williams D
Perspect Behav Sci. 2023; 46(2):261-304.
PMID: 37425985
PMC: 10323060.
DOI: 10.1007/s40614-023-00379-w.
Shurtz L, Schwartz C, DiStefano C, McPartland J, Levin A, Dawson G
Autism. 2022; 27(4):952-966.
PMID: 36086805
PMC: 9995606.
DOI: 10.1177/13623613221121425.
Wiggins L, Nadler C, Rosenberg S, Moody E, Reyes N, Reynolds A
J Pediatr. 2021; 232:264-271.
PMID: 33493493
PMC: 8174527.
DOI: 10.1016/j.jpeds.2021.01.043.
Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.
Pearson D, Santos C, Aman M, Eugene Arnold L, Lane D, Loveland K
J Child Adolesc Psychopharmacol. 2020; 30(7):414-426.
PMID: 32644833
PMC: 7475091.
DOI: 10.1089/cap.2020.0004.
Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016.
Xu G, Strathearn L, Liu B, OBrien M, Kopelman T, Zhu J
JAMA Pediatr. 2018; 173(2):153-159.
PMID: 30508021
PMC: 6439607.
DOI: 10.1001/jamapediatrics.2018.4208.
The Nature of Family Meals: A New Vision of Families of Children with Autism.
Curtiss S, Ebata A
J Autism Dev Disord. 2018; 49(2):441-452.
PMID: 30136117
DOI: 10.1007/s10803-018-3720-9.
Prescription trends in children with pervasive developmental disorders: a claims data-based study in Japan.
Satoh M, Obara T, Nishigori H, Ooba N, Morikawa Y, Ishikuro M
World J Pediatr. 2016; 12(4):443-449.
PMID: 27286689
DOI: 10.1007/s12519-016-0036-8.
Clinical Correlates of Co-occurring Psychiatric and Autism Spectrum Disorder (ASD) Symptom-Induced Impairment in Children with ASD.
Gadow K, Perlman G, Ramdhany L, de Ruiter J
J Abnorm Child Psychol. 2015; 44(1):129-39.
PMID: 25640910
DOI: 10.1007/s10802-015-9979-9.
Mental health services for individuals with high functioning autism spectrum disorder.
Lake J, Perry A, Lunsky Y
Autism Res Treat. 2014; 2014:502420.
PMID: 25276425
PMC: 4168143.
DOI: 10.1155/2014/502420.
Aggressive Behavior Problems in Children with Autism Spectrum Disorders: Prevalence and Correlates in a Large Clinical Sample.
Hill A, Zuckerman K, Hagen A, Kriz D, Duvall S, van Santen J
Res Autism Spectr Disord. 2014; 8(9):1121-1133.
PMID: 25221619
PMC: 4160737.
DOI: 10.1016/j.rasd.2014.05.006.
Gender and injuries predict stimulant medication use.
Dalsgaard S, Leckman J, Nielsen H, Simonsen M
J Child Adolesc Psychopharmacol. 2014; 24(5):253-9.
PMID: 24813570
PMC: 4064734.
DOI: 10.1089/cap.2013.0101.
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish....
Dalsgaard S, Nielsen H, Simonsen M
J Child Adolesc Psychopharmacol. 2013; 23(7):432-9.
PMID: 24015896
PMC: 3778945.
DOI: 10.1089/cap.2012.0111.
The missing link: delayed emotional development predicts challenging behavior in adults with intellectual disability.
Sappok T, Budczies J, Dziobek I, Bolte S, Dosen A, Diefenbacher A
J Autism Dev Disord. 2013; 44(4):786-800.
PMID: 24002416
DOI: 10.1007/s10803-013-1933-5.
Is Medication Information for Children with Autism Spectrum Disorder Monitored and Coordinated Across Professionals? Findings from a Teacher Survey.
Koegel L, Krasno A, Taras H, Koegel R, Frea W
School Ment Health. 2013; 5(1):48-57.
PMID: 23526921
PMC: 3603705.
DOI: 10.1007/s12310-012-9098-5.
A review of complementary and alternative treatments for autism spectrum disorders.
Lofthouse N, Hendren R, Hurt E, Eugene Arnold L, Butter E
Autism Res Treat. 2012; 2012:870391.
PMID: 23243505
PMC: 3515887.
DOI: 10.1155/2012/870391.
Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts.
Weeden M, Ehrhardt K, Poling A
Behav Anal Pract. 2012; 3(1):4-12.
PMID: 22479667
PMC: 3004683.
DOI: 10.1007/BF03391753.
Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.
Frazier T, Shattuck P, Narendorf S, Cooper B, Wagner M, Spitznagel E
J Child Adolesc Psychopharmacol. 2011; 21(6):571-9.
PMID: 22166171
PMC: 3279713.
DOI: 10.1089/cap.2011.0057.
High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network.
Logan S, Nicholas J, Carpenter L, King L, Garrett-Mayer E, Charles J
Ann Epidemiol. 2011; 22(1):1-8.
PMID: 22153288
PMC: 3240812.
DOI: 10.1016/j.annepidem.2011.10.007.